Governance

Jatinder Dhaliwal is a registered pharmacist who has served as chief executive officer and director of multiple publicly traded companies listed on Canadian and U.S. exchanges, including the CSE, TSX and Nasdaq.

Mr. Dhaliwal has held chief executive officer and board roles at Akanda Corp., Binovi Technologies Corp., Global Health Clinics Ltd., Virpax Pharmaceuticals, Kiaro Holdings Corp. and EGF Theramed Health Corp. He has also served as a director of Makara Mining, LQR House Inc. and Intact Gold Corp.
Mr. Dhaliwal holds a Bachelor of Pharmacy from the University of British Columbia and a Bachelor of Science in Biology from the University of Victoria.

Katharyn Field is the Chief Executive Officer of iSpecimen Inc. (Nasdaq: ISPC), where she oversees performance improvement and the redevelopment of the company’s proprietary software platform. She previously served as President, Chairman and an independent director of iSpecimen.

Ms. Field has served in senior leadership, corporate development and board roles across multiple public companies, including LogProstyle, Akanda Corporation, Nuwellis, Virpax Pharmaceuticals, Aerwins Technologies, Halo Collective and MariMed.

Ms. Field received her MBA with a concentration in Strategy and Economics from Columbia Business School and a B.A. in Public Policy, with a Minor in Art History, from Stanford University.

Mika Grasso is an Investment Director at a family office, where he oversees the firm’s direct investment and co-investment activities, including portfolio construction and capital deployment across private markets.

Mr. Grasso has held investment banking, capital markets and finance roles at Zions Capital Markets, Paulson Investment Company, Goldman Sachs and Power Systems Management. He previously served as a director of Nuwellis, Inc. (Nasdaq: NUWE).

Mr. Grasso received his M.S. in Finance with a concentration in Investment Management and his B.S. in Business Administration, both from the University of Colorado Boulder, Leeds School of Business.